The trademark application XANSIVIG was filed by Baxalta Incorporated, a U.S. corporation (the "Applicant"). The application was published for oppositions on May 5, 2024, and it was registered by office on August 12, 2024 without any oppositions.
The application was filed in English (German was selected as the second language).